Healthpeak Properties, Inc. is a Standard & Poor's ("S&P") 500 company that owns, operates, and develops high-quality real estate focused on healthcare discovery and delivery in the United States ("U.S."). Our company was originally founded in 1985. We are organized as an umbrella partnership REIT ("UPREIT"). We hold substantially all of our assets and conduct our operations through our operating subsidiary, Healthpeak OP, a consolidated subsidiary of which we are the managing member. We are a Maryland corporation and qualify as a self-administered REIT. We are headquartered in Denver, Colorado, with additional corporate offices in California, Tennessee, Wisconsin, and Massachusetts and property management offices in several locations throughout the U.S. We have a diversified portfolio of high-quality healthcare properties across three core asset classes of outpatient medical, lab, and senior housing real estate. Under the outpatient medical and lab segments, we own, operate, and develop outpatient medical buildings, hospitals, and lab buildings. Under the senior housing segment, our properties are operated through RIDEA structures. We have other non-reportable segments that are comprised primarily of: (i) loans receivable, (ii) a preferred equity investment, and (iii) three other properties. These non-reportable segments have been presented on a combined basis herein.
Business description as filed in the annual report of 3 February 2026 - view on SEC EDGAR.
Logo and founding year from Wikidata.
As recorded by the SEC for this filer.
As recorded by the SEC for this filer.
No related securities.
No related securities.
| Dec FY2014 | 1.6B |
|---|---|
| Dec FY2015 | 1.9B |
| Dec FY2016 | 2.1B |
| Dec FY2017 | 1.8B |
| Dec FY2018 | 1.2B |
| Dec FY2019 | 1.2B |
| Dec FY2020 | 1.6B |
| Dec FY2021 | 1.9B |
| Dec FY2022 | 2.1B |
| Dec FY2023 | 2.2B |
| Dec FY2024 | 2.7B |
| Dec FY2025 | 2.8B |
| Sep Q3 FY23 | 556.2M |
|---|---|
| Dec Q4 FY23 | 553.7M |
| Mar Q1 FY24 | 606.6M |
| Jun Q2 FY24 | 695.5M |
| Sep Q3 FY24 | 700.4M |
| Dec Q4 FY24 | 698M |
| Mar Q1 FY25 | 702.9M |
| Jun Q2 FY25 | 694.3M |
| Sep Q3 FY25 | 705.9M |
| Dec Q4 FY25 | 719.4M |
| Mar Q1 FY26 | 753M |
| Jun Q2 FY26 | 771.6M |